Stocksigma LogoStocksigma Logo

Clinitech Laboratory Reports H1 FY27 Results and Full IPO Proceeds Utilization

Clinitech Laboratory approved its un-audited H1 results for the period ended 30th Sep'26. On a consolidated basis, revenue from operations reached ₹942.41

Clinitech Laboratory Reports H1 FY27 Results and Full IPO Proceeds Utilization

Clinitech Laboratory Ltd · Financial Result · 13 Nov 2026, 7:03 pm

Clinitech Laboratory Reports H1 FY27 Results and Full IPO Proceeds Utilization Clinitech Laboratory approved its un-audited H1 results for the period ended 30th Sep'26. On a consolidated basis, revenue from operations reached ₹942.41 lakhs, up from ₹508.02 lakhs in H1 FY26 (ended 30th Sep'25). Net profit attributable to owners rose to ₹38.33 lakhs compared to ₹30.03 lakhs YoY, yielding a basic and diluted EPS of ₹1.59. Standalone revenue stood at ₹549.32 lakhs with a net profit of ₹24.46 lakhs. The company fully utilized its ₹578.30 lakh IPO proceeds, primarily allocating ₹498.67 lakhs toward diagnostic business expansion.

Original exchange filing (PDF)

More announcements from Clinitech Laboratory Ltd

All Clinitech Laboratory Ltd announcements